跳到正文
原文
Medical Xpress·· 23 天前精选AI 评分65

分析2.44亿美国人数据细化长新冠理解

Analysis of 244 million Americans refines the understanding of long COVID

AI 导读

斯坦福大学研究人员分析了2440万美国人的健康保险记录,发现传统方法可能高估了长新冠的症状范围和持续时间。研究采用合成控制设计,排除了潜在偏见,确认了肌病、非结核性肺炎等为主要长新冠症状。

推荐理由

研究改进了长新冠症状识别方法,有助于更准确评估其影响。

正文
COVID
Credit: Unsplash/CC0 Public Domain

Long COVID is a phenomenon in which serious health effects linger well after a patient tests negative for coronavirus infection. Patients describe persistent "brain fog," fatigue, dizziness, rapid heart rate, shortness of breath and chest pain, among symptoms that affect nearly every organ system in the body and last a year or more after the infection has passed.

In a new study, data scientists at Stanford University combed a massive data set of 14.4 billion health insurance records from more than 244 million Americans and found that conventional methods may substantially overestimate the range and duration of health effects attributable to COVID-19.

"Our new study design found 98% fewer long COVID–attributable outcomes between four and 12 months after infection compared with conventional approaches applied in the same data set," said co-senior author Jure Leskovec, a professor of computer science. "This doesn't mean long COVID is 98% less common. It means that how we design these studies fundamentally changes which health effects we can reliably attribute to COVID."

The results are published in the journal Proceedings of the National Academy of Sciences.

Improving population-level studies

Beyond its implications for understanding long COVID itself, this research carries an important message about how researchers can better design future population-level health studies, Leskovec said.

Improvements suggested by this work could help reduce biases that lead to skewed or unreliable results. Huge quantities of data are valuable to the extent they can reveal subtle patterns and help rule out implausible associations, but scale alone cannot overcome bias, the authors say.

"Even with 244 million patients, you can get highly precise answers to the wrong question," said Leskovec. "Study design matters as much as data size."

Scientists need to be as rigorous, careful and thoughtful as physicians, argue the authors. They must test for positive associations, Leskovec explained, but also run control checks and explore negative associations as a stress test of their assumptions and approaches.

"This study used a synthetic-control design that is popular in economics and in the social sciences to align patient histories for cases and controls," said co-senior author Stefan Wager, an associate professor of operations, information and technology at Stanford Graduate School of Business. "It was exciting to see its promise applied to a large-scale medical study. I'm hopeful that there are many other applications where synthetic-control methods can yield valuable insights when applied to electronic health records or claims data."

"You can take this messy, noisy data and, with the right study design, get real signal out of it," said first author Hamed Nilforoshan, a doctoral student in computer science working in Leskovec's lab. "Data at this scale was basically out of reach for clinical research before, because people didn't trust it. We show it can work."

Bias revealed

Nilforoshan first set out to reproduce the results of other high-profile long COVID studies that suggested the disease had an unusually broad range of symptoms, some persisting for extended periods. He was able to match their findings exactly if he used their approach. But then he started to dig deeper. He looked to see whether long COVID appeared to cause impossible outcomes—lightning strikes, dog bites and gunshot wounds—and found that it did.

"Something wasn't adding up," Nilforoshan said.

The problem was a phenomenon known as confounding bias—systematic differences between the compared populations that also affect the outcome. Earlier studies compared people who tested positive for COVID with people who were never diagnosed, including people who were not tested. The flaw in that design is that people who choose to get tested differ systematically from those who do not, which was confirmed in this study.

They may have underlying conditions or a non-COVID infection, or just seek medical care more frequently. Ignoring those differences can create misleading associations between COVID and subsequent health problems.

Leskovec clarifies the subtlety: "If you compare people who tested positive for COVID with people who were never tested, you risk attributing differences in their underlying health and health care–seeking behavior to the virus itself."

Instead, the researchers selected only patients getting their first PCR test for COVID and compared the long-term outcomes of those who tested positive with those who tested negative. This helped them isolate COVID's real symptoms and measure their duration more accurately.

Then they used negative controls to stress-test their hypotheses by returning to Nilforoshan's aforementioned unlikely outcomes—lightning strikes, dog bites, gunshots and so forth.

"A reliable method should not identify those outcomes as the effect of long COVID," said Leskovec. As expected, those outcomes were not flagged. "These negative controls give us greater confidence that we're identifying genuine COVID-attributable effects," Leskovec explained. The study listed myopathy, non-TB pneumonia, respiratory issues and pneumothorax among the top COVID-attributable effects it verified.

"These findings indicate that long COVID may be more similar to other extended postviral syndromes than many have thought," said author Steven Goodman, professor of epidemiology and population health in the Stanford School of Medicine.

"From a scientific perspective, this was a true team effort. Harmonizing the research cultures and methods of computer science, statistics and epidemiology was essential to providing this important evidence on the nature of long COVID, yielding a product better than any of us could have created alone."

Real-world advice

For doctors and patients, the study changes little. Long COVID is real. It can last months and affect multiple organ systems. The study suggests that the additional health risks attributable to COVID diminish more quickly at the population level than earlier estimates indicated, although some patients may continue to experience symptoms for a year or longer.

The researchers caution that insurance records cannot capture every patient experience, particularly symptoms such as fatigue and cognitive difficulties that may go undiagnosed or unrecorded.

"These results should complement physicians' clinical assessments, not replace them," Leskovec says. "On the other hand, for data scientists, earlier long COVID studies might need to be revisited with better controls. Our approach could improve those and future population-health studies."

Publication details

Hamed Nilforoshan et al., Revised estimates of types and duration of long COVID symptoms based on claims records from 245 million US patients, Proceedings of the National Academy of Sciences (2026). DOI: 10.1073/pnas.2604414123

Journal information: Proceedings of the National Academy of Sciences

Who's behind this story?

Swati Mestri

Swati Mestri

Swati Mestri holds a bachelor's degree in Electronics Engineering and has worked as a content editor since 2019. She has experience editing research documents across technology, health care, and materials science, and has a particular interest in technology and space. Full profile →

Robert Egan

Robert Egan

Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →

Citation: Analysis of 244 million Americans refines the understanding of long COVID (2026, October 28) retrieved 28 October 2026 from https://medicalxpress.com/news/2026-10-analysis-million-americans-refines-covid.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

来源:Medical Xpress · medicalxpress.com